Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “High Dose Rate Brachytherapy”

95 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 95 results

Not applicableLooking for participantsNCT06398938
What this trial is testing

Evaluation of Ultraaccelerated High Dose Rate Intrauterine Interventional Radiotherapy

Who this might be right for
Locally Advanced Cervical Carcinoma
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 129
Testing effectiveness (Phase 2)Study completedNCT00039624
What this trial is testing

Magnetic Resonance-Guided High-Dose Brachytherapy (Short-Range Radiation Therapy) for Prostate Cancer

Who this might be right for
Prostate Cancer
National Cancer Institute (NCI) 12
Not applicableStudy completedNCT02346253
What this trial is testing

High-Dose Brachytherapy in Treating Patients With Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaStage I Prostate CancerStage IIA Prostate Cancer+2 more
Stanford University 146
Not applicableLooking for participantsNCT07343531
What this trial is testing

Moderately Hypo-Fractionated External-beam Radiotherapy With Concurrent Chemotherapy and High Dose Rate Brachytherapy In Cervical Cancer

Who this might be right for
Cervical Carcinoma Stage IIICervical Carcinoma Stage IIBCervical Carcinoma Stage II
Ain Shams University 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT05003752
What this trial is testing

Hypo-Combi Trial: Hypofractionated EBRT Plus HDR-BT Boost for Prostate Cancer

Who this might be right for
Prostate AdenocarcinomaRadiation Toxicity
German Oncology Center, Cyprus 40
Testing effectiveness (Phase 2)Ended earlyNCT00983541
What this trial is testing

Chemoradiation +Gemcitabine +Continuous 5-FU (Fluorouracil) Followed by High Dose Brachytherapy/Stereotactic Radiation Boost in Locally Advanced Intra/Extrahepatic Cholangiocarcinoma

Who this might be right for
Cancer
University of Utah 1
Not applicableActive Not RecruitingNCT03312972
What this trial is testing

Focal Salvage HDR Brachytherapy for Locally Recurrent Prostate Cancer in Patients Treated With Prior Radiotherapy

Who this might be right for
Locally Recurrent Prostate Cancer
Loyola University 50
Testing effectiveness (Phase 2)UnknownNCT01175694
What this trial is testing

Dose Optimization for Pulsed-dose-rate (PDR)/High-dose-rate (HDR) Brachytherapy Alone for Early Breast Cancer

Who this might be right for
Breast Cancer
University Hospital Erlangen 200
Testing effectiveness (Phase 2)Study completedNCT02526498
What this trial is testing

Accelerated Partial Breast Radiation Therapy Using High-Dose Rate Brachytherapy in Treating Patients With Early Stage Breast Cancer After Surgery

Who this might be right for
Ductal Breast Carcinoma In SituEstrogen Receptor PositiveInvasive Breast Carcinoma+4 more
Rutgers, The State University of New Jersey 200
Not applicableUnknownNCT03110497
What this trial is testing

Single Application Brachytherapy in Cervical Cancer

Who this might be right for
Cervical Cancer
Tata Memorial Hospital 40
Testing effectiveness (Phase 2)Active Not RecruitingNCT04253483
What this trial is testing

Comparison of High-Dose Rate Brachytherapy and Stereotactic Ablative Radiotherapy as Monotherapy for the Treatment of Localized Prostate Cancer

Who this might be right for
Stage I Prostate Cancer AJCC v8Stage II Prostate Cancer AJCC v8Stage IIA Prostate Cancer AJCC v8+2 more
Rutgers, The State University of New Jersey 14
Testing effectiveness (Phase 2)Looking for participantsNCT07182279
What this trial is testing

Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer

Who this might be right for
Prostate Cancer (Adenocarcinoma)
The Methodist Hospital Research Institute 29
Testing effectiveness (Phase 2)Looking for participantsNCT03424850
What this trial is testing

Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate Brachytherapy

Who this might be right for
Prostate CancerProstate Neoplasm
Washington University School of Medicine 36
Not applicableLooking for participantsNCT04945642
What this trial is testing

High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma

Who this might be right for
Prostate AdenocarcinomaStage IIB Prostate Cancer American Joint Committee on Cancer (AJCC) v8Stage IIC Prostate Cancer AJCC v8+5 more
Jonsson Comprehensive Cancer Center 52
Testing effectiveness (Phase 2)Study completedNCT00091390
What this trial is testing

Radiation Therapy in Treating Patients With Stage II or Stage III Prostate Cancer

Who this might be right for
Prostate Cancer
Radiation Therapy Oncology Group 129
Not applicableWithdrawnNCT04645810
What this trial is testing

Focal Salvage High-Dose-Rate Brachytherapy for Prostate Gland Only Recurrence

Who this might be right for
Prostate CancerHDR
University of Rochester
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06524778
What this trial is testing

Single High-dose Brachytherapy for Giant Osteosarcoma Masses

Who this might be right for
Osteosarcoma
Shanghai Jiao Tong University Affiliated Sixth People's Hospital 16
Not applicableNot Yet RecruitingNCT05614700
What this trial is testing

Prostate Reirradiation Toxicity Outcomes Feasibility Study

Who this might be right for
Prostate CancerRadiotherapy Side Effect
University of Leeds 60
Large-scale testing (Phase 3)UnknownNCT02258087
What this trial is testing

HDR vs LDR Brachytherapy as Monotherapy in the Treatment of Localized Prostate Cancer.

Who this might be right for
Adenocarcinoma of Prostate
National Institute of Oncology, Hungary 50
Not applicableWithdrawnNCT02597894
What this trial is testing

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Who this might be right for
Stage III Prostate Adenocarcinoma
Jonsson Comprehensive Cancer Center
Next Page